
The broader market, however, underperformed the main equity benchmark indices, with the NIFTY Midcap 100 falling 0.51% while the NIFTY Smallcap 100 declined 1.1%.
as of 21/11/2026, 7:14:15 pm
02/Price history
1 day · 5-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
No candles for this range
Intraday candles are empty outside market hours — pick a longer range.
No candles in this range
03/Valuation & returns
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 2%
Price ÷ book value per share
Worse than sector by 309%
Net income ÷ total assets
Better than sector by 130%
Net income ÷ shareholders' equity
Better than sector by 166%
EBIT ÷ capital employed
Better than sector by 59%
Liquid assets ÷ current liabilities
Worse than sector by 97%
Enterprise value ÷ EBITDA
Worse than sector by 28%
04/Business
Sector: Healthcare Services
Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 plus beds across 73 hospitals, 5000 plus pharmacies and 378 plus clinics and diagnostic centers, as well as 200 telemedicine centers.
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.
| Revenue | 24,961 | 21,994 | 19,166 | 16,703 |
|---|---|---|---|---|
| Revenue growthreported | 13.5% | 14.8% | 14.7% | — |
| Operating profit | 2,672 | 2,039 | 1,381 | 1,101 |
| Operating profit growthreported | 31.0% | 47.7% | 25.4% | — |
| Operating marginderived | 10.7% | 9.3% | 7.2% | 6.6% |
| Net profit | 2,003 | 1,505 | 935 | 844 |
| Net profit growthreported | 33.1% | 61.0% | 10.7% | — |
| Net marginderived | 8.0% | 6.8% | 4.9% | 5.1% |
| EPS — basic₹/share, annual | 135.04 | 100.56 | 62.50 | 56.97 |
Figures in ₹ crore. Margin rows are computed from the reported values.
| Revenue | 25,229 | 21,794 | 19,059 | 16,613 |
|---|---|---|---|---|
| Other Income | 192 | 200 | 106 | 90 |
| Total Revenue | 25,420 | 21,994 | 19,166 | 16,703 |
| Total Expenses | 22,785 | 19,988 | 17,805 | 15,559 |
| Profit Before Tax | 2,661 | 2,039 | 1,381 | 1,144 |
| Tax | 658 | 534 | 446 | 256 |
| Profit After Tax | 2,003 | 1,505 | 935 | 888 |
| EPS - Basic | 135.04 | 100.56 | 62.50 | 56.97 |
| EPS - Diluted | 134.94 | 100.56 | 62.50 | 56.97 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
| Total assets | 22,197 | 20,657 | 16,753 | 14,428 |
|---|---|---|---|---|
| Total liabilities | 12,222 | 12,005 | 9,433 | 7,897 |
| Net worthderived | 9,975 | 8,653 | 7,320 | 6,531 |
| Liabilities ÷ assetsderived | 55.1% | 58.1% | 56.3% | 54.7% |
| Asset growthderived | 7.5% | 23.3% | 16.1% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
| Non-Current Assets | 15,297 | 13,629 | 11,473 | 10,091 |
|---|---|---|---|---|
| Current Assets | 6,900 | 7,029 | 5,280 | 4,337 |
| Total Assets | 22,197 | 20,657 | 16,753 | 14,428 |
| Current Liabilities | 6,481 | 4,579 | 4,665 | 3,325 |
| Net Current Asset | 419 | 2,450 | 615 | 1,012 |
| Non-Current Liabilities | 5,741 | 7,426 | 4,768 | 4,572 |
| Equity Capital | 9,975 | 8,653 | 7,321 | 6,531 |
| Total Equity & Liabilities | 22,197 | 20,657 | 16,753 | 14,428 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
| Operating activities | 2,856 | 2,136 | 1,920 | 1,377 |
|---|---|---|---|---|
| Operating changereported | 33.7% | 11.3% | 39.5% | — |
| Investing activities | -2,148 | -3,383 | -1,537 | -871 |
| Investing changereported | 36.5% | -120.1% | -76.6% | — |
| Financing activities | -478 | 1,319 | -311 | -633 |
| Financing changereported | -136.2% | 524.2% | 50.9% | — |
| Net cash flowderived | 230 | 73 | 72 | -127 |
| Free cash flowoperating + investing | 708 | -1,247 | 383 | 506 |
Figures in ₹ crore.
| Profit before tax | 2,003 | 1,505 | 935 | 844 |
|---|---|---|---|---|
| Income before WC changes | 4,036 | 3,226 | 2,580 | 2,209 |
| Change in Assets | -770 | -594 | -641 | -782 |
| Change in Liabilities | 196 | -9 | 448 | 332 |
| Change in WC | -574 | -604 | -193 | -450 |
| Cash flow from Operations | 2,856 | 2,136 | 1,920 | 1,377 |
| Cash flow from Investing | -2,148 | -3,383 | -1,537 | -871 |
| Cash flow from Financing | -478 | 1,319 | -311 | -633 |
| Total Cash Flow | 230 | 73 | 72 | -127 |
| Cash (Start of the year) | 578 | 506 | 433 | 547 |
| Cash (End of the year) | 811 | 578 | 506 | 433 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
| DividendFinal | ₹10.00 | 200.0% | 14 Aug 2026 | 14 Aug 2026 | 20 May 2026 | |
| DividendInterim | ₹10.00 | 200.0% | 16 Feb 2026 | 16 Feb 2026 | 10 Feb 2026 |
10/Comparison
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B | |
| MOLBIOMolbio Diagnostics Ltd | Healthcare | ₹1,495.50 | -2.02% | 7.01 L | ₹17,228 Cr | $1.91B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Articles published in the last seven days, paginated by the provider.

The broader market, however, underperformed the main equity benchmark indices, with the NIFTY Midcap 100 falling 0.51% while the NIFTY Smallcap 100 declined 1.1%.